Page 178 - Withrow and MacEwen's Small Animal Clinical Oncology, 6th Edition
P. 178
CHAPTER 8 Molecular Diagnostics 157
55. London CA, AL Hannah, Zadovoskaya R, et al.: Phase I dose-esca- 57. Paoloni M, Webb C, Mazcko C, et al.: Prospective molecular pro-
lating study of SU11654, a small molecule receptor tyrosine kinase filing of canine cancers provides a clinically relevant comparative
inhibitor, in dogs with spontaneous malignancies, Clin Cancer Res model for evaluating personalized medicine (PMed) trials, PLoS One
VetBooks.ir 56. Von Hoff DD, Stephenson Jr JJ, Rosen P, et al.: Pilot study using 9:e90028, 2014.
9:2755–2768, 2003.
molecular profiling of patients’ tumors to find potential targets and
select treatments for their refractory cancers, J Clin Oncol 28:4877–
4883, 2010.
